An abnormal phenotype of lung Vγ9Vδ2 T cells impairs their responsiveness in tuberculosis patients

Cellular Immunology

Volumn 282, Issue 2, 2013, Pages 106-112

  El Daker, Sary ^a,c,d   Sacchi, Alessandra ^a   Montesano, Carla ^c   Altieri, Alfonso Maria ^b   Galluccio, Giovanni ^b   Colizzi, Vittorio ^c   Martini, Federico ^a   Martino, Angelo ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d AGENCY FOR SCIENCE   (Singapore)

Author keywords

T cells; Lung; Mycobacterium; Primary infection

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG ALVEOLUS CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; TUBERCULOSIS;

ΓΔ T CELLS; LUNG; MYCOBACTERIUM; PRIMARY INFECTION;

ADOLESCENT; ADULT; ANTIGENS, CD3; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; LUNG; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, IGG; RECEPTORS, NATURAL KILLER CELL; T-LYMPHOCYTES; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

MYCOBACTERIUM;

EID: 84879188122     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.05.001     Document Type: Article

References (39)

1. Vashishtha V.M. WHO global tuberculosis Control Report 2009: tuberculosis elimination is a distant dream. Indian Pediatr. 2009, 46(2009):401-402.
2. Wright A., et al. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the global project on anti-tuberculosis drug resistance surveillance. Lancet 2009, 373:1861-1873.
3. Barker L.F., Brennan M.J., Rosenstein P.K., Sadoff J.C. Tuberculosis vaccine research: the impact of immunology. Curr. Opin. Immunol. 2009, 21:331-338.
4. Korbel D.S., Schneider B.E., Schaible U.E. Innate immunity in tuberculosis: myths and truth. Microbes Infect. 2008, 10:995-1004.
5. Martino A. Mycobacteria and innate cells: critical encounter for immunogenicity. J. Biosci. 2008, 33:137-144.
6. Casetti R., Martino A. The plasticity of gamma delta T cells: innate immunity, antigen presentation and new immunotherapy. Cell. Mol. Immunol. 2008, 5:161-170.
7. Chiplunkar S., Dhar S., Wesch D., Kabelitz D. Gammadelta T cells in cancer immunotherapy: current status and future prospects. Immunotherapy 2009, 1:663-678.
8. Chien Y.H., Konigshofer Y. Antigen recognition by gammadelta T cells. Immunol. Rev. 2007, 215:46-58.
9. Battistini L., et al. Homing and memory patterns of human gammadelta T cells in physiopathological situations. Microbes Infect. 2005, 7:510-517.
10. -V gamma 9V delta 2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis. J. Immunol. 2002, 168:1484-1489.
11. Holoshitz J., Koning F., Coligan J.E., De Bruyn J., Strober S. Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 1989, 339:226-229.
12. Shen Y., et al. Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections. Science 2002, 295:2255-2258.
13. Ito M., et al. Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis. Chest 1992, 102:195-197.
14. Dieli F., et al. Vgamma9/Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis. Eur. J. Immunol. 2000, 30:1512-1519.
15. Balbi B., et al. T-lymphocytes with gamma delta+ V delta 2+ antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis. Am. Rev. Respir. Dis. 1993, 148:1685-1690.
16. Kabelitz D., et al. The primary response of human gamma/delta + T cells to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells. J. Exp. Med. 1991, 173:1331-1338.
17. Schwander S.K., et al. T lymphocitic and immature macrophage alveolitis in active pulmonary tuberculosis. J. Infect. Dis. 1996, 1267-1272.
18. Meraviglia S., Caccamo N., Salerno A., Sireci G., Dieli F. Partial and ineffective activation of Vg9Vd2 T cells by Mycobacterium tuberculosis-infected dendritic cells. J. Immunol. 2010, 185:1770-1776.
19. Kabelitz D. Effector functions and control of human γδ T-cell activation. Microbes Infect. 1999, 255-261.
20. + alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. J. Immunol. 1995, 154:1786-1796.
21. Ismaili J., et al. Clin. Immunol. 2002, 296-302.
22. Stenger S., Modlin R.L. T cell mediated immunity to Mycobacterium tuberculosis. Curr. Opin. Microbiol. 1999, 2:89-93.
23. Li B., et al. Disease-specific changes in gammadelta T cell repertoire and function in patients with pulmonary tuberculosis. J. Immunol. 1996, 157:4222-4229.
24. Barnes P.F., et al. Gamma delta T lymphocytes in human tuberculosis. J. Infect. Dis. 1992, 165:506-512.
25. Uyemura K., et al. Gamma delta T cells in leprosy lesions. Curr. Top Microbiol. Immunol. 1991, 173:203-207.
26. Follows G.A., Munk M.E., Gatrill A.J., Conradt P., Kaufmann S.H. Gamma interferon and interleukin 2, but not interleukin 4, are detectable in gamma/delta T-cell cultures after activation with bacteria. Infect. Immun. 1992, 60:1229-1231.
27. Lanzavecchia A., Lezzi G., Viola A. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell 1999, 96:1-4.
28. Valitutti S., Muller S., Dessing M., Lanzavecchia A. Signal extinction and T cell repolarization in T helper cell-antigen-presenting cell conjugates. Eur. J. Immunol. 1996, 26:2012-2016.
29. Liu H., Rhodes M., Wiest D.L., Vignali D.A. On the dynamics of TCR: CD3 complex cell surface expression and downmodulation. Immunity 2000, 13:665-675.
30. Ali Z., et al. Prolonged (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate-driven antimicrobial and cytotoxic responses of pulmonary and systemic Vgamma2Vdelta2 T cells in macaques. J. Immunol. 2007, 179:8287-8296.
31. Sicard H., et al. In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model. J. Immunol. 2005, 175:5471-5480.
32. Szereday L., Baliko Z., Szekeres-Bartho J. The role of Vdelta2+T-cells in patients with active Mycobacterium tuberculosis infection and tuberculin anergy. Int. J. Tuberc. Lung Dis. 2008, 12:262-268.
33. D'Ombrain M.C., Hansen D.S., Simpson K.M., Schofield L. Gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria. Eur. J. Immunol. 2007, 37:1864-1873.
34. Lesport E., et al. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer. Cell. Mol. Life Sci. 2011, 68:3385-3399.
35. Yokobori N., et al. CD3 expression distinguishes two gammadeltaT cell receptor subsets with different phenotype and effector function in tuberculous pleurisy. Clin. Exp. Immunol. 2009, 157:385-394.
36. O'Shea J.J., Weissman A.M., Kennedy I.C., Ortaldo J.R. Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain. Proc. Natl. Acad. Sci. USA 1991, 88:350-354.
37. Kanakaraj P., et al. Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction. J. Exp. Med. 1994, 179:551-558.
38. Lafont V., Liautard J., Liautard J.P., Favero J. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen. J. Immunol. 2001, 166:7190-7199.
39. Havlir D.V., Ellner J.J., Chervenak K.A., Boom W.H. Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. J. Clin. Invest. 1991, 87:729-733.